Trial Profile
A Prospective, Randomised, Open-labeled, Parallel Group Study to Assess the Efficacy and Safety of Low Dose Ticagrelor Compared With Standard Dose Ticagrelor in Patients With Unstable Angina Pectoris After Drug Eluting Stent Implantation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Coronary artery disease
- Focus Adverse reactions
- 30 Sep 2018 Status changed from not yet recruiting to recruiting.
- 17 Aug 2018 New trial record